4.1.18. 1-(3,4,5-Trimethoxybenzoyl)indoline-5-sulfonamide (4m)

SK Stepan K. Krymov
AS Alexander M. Scherbakov
LD Lyubov G. Dezhenkova
DS Diana I. Salnikova
SS Svetlana E. Solov’eva
DS Danila V. Sorokin
DV Daniela Vullo
VL Viviana De Luca
CC Clemente Capasso
CS Claudiu T. Supuran
AS Andrey E. Shchekotikhin
request Request a Protocol
ask Ask a question
Favorite

This compound was prepared from 9 and 3,4,5-trimethoxybenzoyl chloride as described for 4a. A white powder, yield 58%, mp = 248–250 °C. HPLC (LW = 300 nm, gradient B 30/70/30% (35 min)) tR = 10.9 min, purity 99%. 1H NMR (400 MHz, DMSO-d6): δ 7.85 (br s, 1H, Ar), 7.68 (s, 1H, Ar), 7.64 (d, J = 8.3 Hz, 1H, Ar), 7.24 (s, 2H, NH2), 6.90 (s, 2H, Ar), 4.10 (t, J = 8.2 Hz, 2H, CH2), 3.79 (s, 6H, 2OMe), 3.71 (s, 3H, OMe), 3.13 (t, J = 8.2 Hz, 2H, CH2). 13C NMR (100 MHz, DMSO-d6): δ 168.7, 153.3 (2C), 145.9, 139.5 (2C), 134.1, 132.2, 125.7, 122.9, 116.3, 105.1 (2C), 60.6, 56.6 (2C), 51.3, 27.8. HRMS (ESI) (m/z) [M+H]+: calculated for C18H21N2O6S 393.1115, found 333.1106. IR ν max, (film) cm−1 3336 s, 3189 m, 3079 w, 1644 s, 1592 m, 1566 w, 1539 w, 1482 s, 1433 m, 1394 s, 1333 s, 1315 s, 1257 m, 1194 s, 1169 m, 1152 s, 1111 w, 1079 s, 999 w, 912 s, 892 s, 869 s, 835 s, 802 s, 772 w, 741 w, 714 m, 683 w.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A